antifungals

Juliette Pavie Claire Lacroix Dea Garcia Hermoso Marie Robin Christèle Ferry Anne Bergeron Martine Feuilhade Françoise Dromer Eliane Gluckman Jean-Michel Molina Patricia Ribaud

Aspergillus ustus is an uncommon clinical species which is poorly susceptible to antifungals. We report two cases of A. ustus infections that occurred in allogeneic stem cell transplant recipients while they were receiving either voriconazole or caspofungin. Prolonged use of these new antifungal agents may increase the risk of the emergence of resistant organisms.

متن کامل

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید

Are prophylactic antifungals in highly colonized patients safe and effective?

Ribosomal P-protein Stalk Function Is Targeted by Sordarin Antifungals

Engineering Plant Synthetic Pathways for the Biosynthesis of Novel Antifungals

In vitro susceptibilities of zygomycetes to conventional and new antifungals

In Vitro Interactions between Antifungals and Immunosuppressive Drugs against Zygomycetes

Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.

Crystallization of Erg11p – the cytochrome P450 target of triazole antifungals

Exploiting mitochondria as targets for the development of new antifungals

Vaginal yeasts in the era of "over the counter" antifungals

TheAspergillus nigergrowth on the treated concrete substrate using variable antifungals